Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Gross Profit: 2019-2024

Historic Gross Profit for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to $194.4 million.

  • GeneDx Holdings' Gross Profit rose 76.73% to $84.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $280.1 million, marking a year-over-year increase of 76.23%. This contributed to the annual value of $194.4 million for FY2024, which is 115.98% up from last year.
  • Per GeneDx Holdings' latest filing, its Gross Profit stood at $194.4 million for FY2024, which was up 115.98% from $90.0 million recorded in FY2023.
  • Over the past 5 years, GeneDx Holdings' Gross Profit peaked at $194.4 million during FY2024, and registered a low of -$26.8 million during FY2022.
  • Over the past 3 years, GeneDx Holdings' median Gross Profit value was $90.0 million (recorded in 2023), while the average stood at $85.9 million.
  • As far as peak fluctuations go, GeneDx Holdings' Gross Profit slumped by 512.37% in 2021, and later soared by 436.47% in 2023.
  • GeneDx Holdings' Gross Profit (Yearly) stood at $4.0 million in 2020, then slumped by 512.37% to -$16.6 million in 2021, then tumbled by 61.13% to -$26.8 million in 2022, then surged by 436.47% to $90.0 million in 2023, then soared by 115.98% to $194.4 million in 2024.